Vir-2218
-
【Product for Licensing】siRNA Therapeutics Targeting PD-L1 for HBV
If you are interested in this asset or need more information, please kindly contact DrugTimes BD Team at BD@drugtimes.cn, we will present the non-confidential deck to you for review asap. Many thanks!~
-
全球乙肝新药进展（内含EASL2020新药最新研究结果）
原文始发于微信公众号（药时代）：全球乙肝新药进展（内含EASL2020新药最新研究结果） ⬆️欢迎走进博腾药时代直播间！ 编者按：Hepatitis B Foundation网站开…
